Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1060028020925558 http://scihub22266oqcxt.onion/10.1177/1060028020925558 32389025!ä!32389025 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Pharmacother 2020 ; 54 (8): 827-831 Nephropedia Template TP {{tp|p=32389025|t=2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 |pdf=|usr=}}{{32389025}} gab.com Text Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 JO: Ann Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32389025 #FOAvip The world is suffering a respiratory pandemic disease caused by a novel coronavirus (2019-nCoV), commonly known as COVID-19 (coronavirus disease 2019). The Food and Drug Administration issued an emergency authorization for chloroquine and hydroxychloroquine as experimental treatments for COVID-19 leading to a shortage of both medications. A literature review conducted in April 2020 shows a lack of high-quality data available, resulting in ambiguous guideline recommendations. Decisions to use either drug should be made with careful consideration of risks versus benefits along with proper monitoring. Because of its higher potency and better safety profile, hydroxychloroquine may be the more reasonable treatment option if treatment is initiated. Twit Text FOAVip Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 ????Ann Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32389025 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32389025 #FOAvip English Wikipedia <ref>{{Cite pmid|32389025}}</ref> Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 #MMPMID32389025 Piszczatoski CR; Powell J Ann Pharmacother 2020[Aug]; 54 (8): 827-831 PMID32389025show ga The world is suffering a respiratory pandemic disease caused by a novel coronavirus (2019-nCoV), commonly known as COVID-19 (coronavirus disease 2019). The Food and Drug Administration issued an emergency authorization for chloroquine and hydroxychloroquine as experimental treatments for COVID-19 leading to a shortage of both medications. A literature review conducted in April 2020 shows a lack of high-quality data available, resulting in ambiguous guideline recommendations. Decisions to use either drug should be made with careful consideration of risks versus benefits along with proper monitoring. Because of its higher potency and better safety profile, hydroxychloroquine may be the more reasonable treatment option if treatment is initiated. |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Chloroquine/adverse effects/*therapeutic use[MESH] |Coronavirus Infections/*drug therapy[MESH] |Emergencies[MESH] |Humans[MESH] |Hydroxychloroquine/adverse effects/*therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH]Emergency Authorization of Chloroquine and Hydroxychloroquine for Trea(epmc).pdf DeepDyve Pubget Overpricing